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ABSTRACT 
 
Background 
Tuberculosis (TB) remains a major cause of disease and death worldwide. In 2008, South 
Africa ranked third in the world in terms of the total numbers of new TB cases. Little is 
known about the profile of TB deaths at individual hospital level. Hence, the aim of the study 
was to describe the profile of TB deaths in Charles Hurwitz TB Hospital for the period 
January to December 2007.  
 
Methods  
A descriptive study was done, based on retrospective record review of all patients who died 
between January and December 2007 at Charles Hurwitz TB Hospital, irrespective of the date 
of admission. The data was analysed using Microsoft Excel.  
 
Findings 
 
The mean age at death was 41 years (standard deviation =10.9 years). Less than half of 
deceased individuals were employed (43.4%), more than one third had a history of smoking 
(42%) and the majority had a history of alcohol consumption (60.5%). Almost three quarters 
of the patients (75.3%) were being treated for the first time. The majority (85.1%) of 
deceased patients tested for HIV were HIV positive, but only 23.3% of those referred for 
treatment were actually on ART, indicating missed opportunities in treatment and care at the 
hospital.   
 
Conclusion 
There is need for ongoing vigilance and training to ensure that TB hospitals and individual 
health care providers comply with the national quality of care and TB management standards, 
and that missed opportunities are eliminated to reduce avoidable TB deaths. 
  
v 
 
ACKNOWLEDGEMENTS 
 
I first and foremost thank God Almighty, from whom all blessings flow and who gave me 
strength to complete this study.  
 
I would also like to express my sincere gratitude to all those who contributed to the 
successful compilation of this study. My special appreciation goes to my brother Molapo 
Henry Stone, for his support throughout the period of the compilation of this research report. 
I thank my mother, Nellie Mampempe Stone for her moral support and encouragement. To 
my children and grandchildren, thank you for your understanding when I was unable to fulfil 
your demands. 
 
To my only four months supervisor, Professor Laetitia Rispel, your contributions and support 
are recognised and counted in the highest office. You are amazing. Your efforts are noted and 
you will reap in abundance your blessings. Mrs. Busi Ngoyi, you are a real angel, you did 
everything in your power to ensure that I complete the research report. Dr Gill Nelson, 
research coordinator, thank you for taking it upon yourself to ensure that my registration was 
smooth and for dealing with unnecessary blockages. I wish to acknowledge the assistance of 
Mrs. Dikgapha Khumalo with the formatting of the document.  
 
To Alfred Musekiwa and Ngoni Nyambuya, thank you for your dedication and willingness to 
assist with data gathering and analysis.  
 
 
 
 
 
 
 
 
 
 
 
vi 
 
 
 TABLE OF CONTENTS 
 
DECLARATION ....................................................................................................................... ii 
DEDICATION ......................................................................................................................... iii 
ABSTRACT .............................................................................................................................. iv 
ACKNOWLEDGEMENTS ....................................................................................................... v 
TABLE OF CONTENTS .......................................................................................................... vi 
LIST OF FIGURES ............................................................................................................... viii 
LIST OF TABLES ................................................................................................................. viii 
LIST OF ACRONYMS &ABBREVIATIONS ........................................................................ ix 
CHAPTER 1: INTRODUCTION .............................................................................................. 1 
1.1 Background ................................................................................................................. 1 
1.2 Problem Statement ...................................................................................................... 6 
1.3 Literature review ......................................................................................................... 6 
1.4 Study Justification and Motivation ........................................................................... 14 
CHAPTER 2: METHODOLOGY ....................................................................................... 16 
2.1 Aim of the Study ....................................................................................................... 16 
2.2 Objectives .................................................................................................................. 16 
2.3 Study setting .............................................................................................................. 16 
2.5  Study Population ...................................................................................................... 17 
2.6 Study period .............................................................................................................. 17 
2.7 Study sample ............................................................................................................. 17 
2.8 Study Design ............................................................................................................. 17 
2.9 Framework of analysis .............................................................................................. 17 
2.10 Data collection ....................................................................................................... 18 
2.11 Data processing and analysis ....................................................................................... 19 
vii 
 
2.12 Study Limitations ......................................................................................................... 19 
 
CHAPTER 3- RESULTS ......................................................................................................... 20 
3.1 Introduction ............................................................................................................... 20 
3.2 Demographic and social profile of deceased TB patients ......................................... 20 
3.3 Clinical profile of deceased TB patients ........................................................................ 22 
3.4 TB-HIV co-infection ................................................................................................. 25 
3.5 Conclusion ................................................................................................................. 27 
CHAPTER 4- DISCUSSION .................................................................................................. 29 
4.1 Introduction ............................................................................................................... 29 
4.2 Socio-demographic information ................................................................................ 29 
4.3 Clinical profile of deceased TB patients ........................................................................ 30 
4.4 TB-HIV co-infection ................................................................................................. 32 
4.5 Missed opportunities in the TB treatment and care continuum ................................ 32 
REFERENCES ........................................................................................................................ 40 
 
  
viii 
 
LIST OF FIGURES 
 
Figure 1: Map of Gauteng with approximate location of Charles Hurwitz Hospital................. 4 
Figure 2: Estimated TB mortality rates among HIV-negative people, 2012 ........................... 10 
Figure 3: Trends in TB death rates for new smear positive PTB cases, 1996-2005 ................ 12 
Figure 4: Leading causes of Years of Life Lost (YLLs): Johannesburg Metro District .......... 13 
Figure 5: Age distribution of deceased TB patients, 2007....................................................... 20 
Figure 6: HIV testing and treatment–deceased TB patients .................................................... 26 
Figure 7: Missed opportunities in the management and care of deceased TB patients ........... 34 
LIST OF TABLES 
Table 1: Overview of ‘The Stop TB Strategy’ ........................................................................... 8 
Table 2: Overview of key TB indicators at Charles Hurwitz Hospital, 2007 .......................... 14 
Table 3: Targets used to frame data collection in the study .................................................... 18 
Table 4:  Information collected from each patient record ........................................................ 19 
Table 5: Age and sex distribution of deceased TB patients, 2007 ........................................... 21 
Table 6: Socio-demographic information on deceased TB patients, 2007 .............................. 21 
Table 7:  Category of deceased TB patients ............................................................................ 22 
Table 8: Deceased TB patients according to ICD 10 codes..................................................... 23 
Table 9: Use of other diagnostic tests ...................................................................................... 24 
Table 10:  Number of RHZE dosages (in months) .................................................................. 25 
Table 11:  Distribution of CD4 count ...................................................................................... 27 
Table 12: Summary of recommendations ................................................................................ 37 
 
  
ix 
 
LIST OF ACRONYMS &ABBREVIATIONS 
 
AIDS Acquired immune-deficiency Syndrome 
AFB Acid-fast bacilli 
ART Antiretroviral Therapy 
BCG Bacille Calmette Guerin  
CCMT Counselling, Care, Management and Therapy 
CFS Cerebrospinal Fluid 
CXR Chest X-ray 
DOT Directly Observed Therapy 
DR-TB Drug-Resistant Tuberculosis 
EPTB Extra-pulmonary Tuberculosis 
FBC Full Blood Count 
GXP GeneXpert 
HAST HIV, Sexually Transmitted infections and  Tuberculosis  
HCT HIV Counselling and Testing 
HIV Human Immuno-deficiency Virus 
ICD-10 International Classification of Disease 10
th
 Revision; ICD-10. 
Code list  
INH Isoniazid 
IPT Isoniazid Preventive Therapy 
MDG Millennium Development Goals 
MDR-TB Multi-Drug Resistant Tuberculosis 
NHLS National Health Laboratory Service 
NTMG National Tuberculosis Management Guidelines 
OR All Other treatment  
PMTCT Prevention of Mother to Child Transmission 
PTB Pulmonary TB 
PZA Pyrazinamide 
RC Relapse after Cure 
RAC Retreatment after completion 
RD Treatment after defaulted after two or more months 
RF Treatment after failure 
RI Treatment interruption 
x 
 
RHZE Rifampicin, Isoniazid, Pyrazinamide and Ethambutol  
RIF Rifampicin 
S Streptomycin 
TAT Turn –around- time 
TB Tuberculosis 
VCT Voluntary Counselling and Testing 
WHO World Health Organisation 
XDR-TB Extensively Drug Resistant TB 
PZA Pyrazinamide 
 
ICD10 CODES 
 
ICD 10 Code Organ Affected 
A15/A16.2 All AFB positive 
A15.2  All PTB 
A16.3 TB of the lymph nodes 
A16.5/A16.8 TB Pleura and other respiratory organs 
A16.7 Primary TB 
A17 TB meningitis 
A18.6/A18.8 TB other organs 
A19/A19.9 TB Miliary 
 
 
1 
 
CHAPTER 1: INTRODUCTION 
 
1.1 Background 
 
Tuberculosis (TB) remains a major cause of disease and death worldwide. In 2008, there 
were an estimated 8.9 to 9.9 million incident (or new) cases of TB, 9.6 to 13.3 million 
prevalent (or existing) cases of TB, 1.1 to 1.7 million deaths from TB among HIV-negative 
people and an additional 0.45 to 0.62 million TB deaths among HIV-positive people (WHO, 
2009). Globally, progress has been made and prevalence and mortality rates are falling in all 
World Health Organization (WHO) regions.  WHO has indicated that the gaps in the Africa 
Region in reaching the targets in the Global Plan are huge (WHO, 2009). WHO has also 
noted that the global target of halving the 1990 mortality rate appears impossible in many 
African countries (WHO, 2009). Africa is the only region to show increases in TB 
prevalence, from an estimated 162 per 100 000 population in 1990 to 480 per 100 000 
population in 2008 (WHO, 2011).  
 
In Sub-Saharan Africa, the TB and HIV epidemics are closely intertwined.  A study found 
that the TB case-fatality rates (proportion of patients dying while on anti-tuberculosis 
treatment) were between 16 to 35% in HIV positive individuals not receiving antiretroviral 
treatment, compared to 9% in HIV negative patients (Ya Diul, Mher, & Harris, 2001). In 
2012, the estimated percentage of TB cases living with HIV remained worldwide at 13% 
(WHO, 2013: p6). 
 
The factors contributing to the increased TB burden in Africa include: poverty and rapid 
urbanisation; the impact of the HIV-pandemic; poor health infrastructure; including 
inadequate laboratory facilities and diagnostic equipment; poor programme management with 
inadequate case detection, diagnosis and cure; and sub-optimal involvement of communities 
and other stakeholders in TB control (WHO, 2009).  
 
South Africa is one of the 22 high-burden countries which combined account for around 80% 
of the total global burden of all TB cases (WHO, 2009). In 2008, South Africa ranked third in 
the world in terms of the total numbers of new TB cases (WHO, 2009). This is because of the 
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complex interrelationship with the HIV epidemic, which accounts for a significant disease 
burden in the country (Day, Gray, & Budgell, 2011; SANAC, 2011). In 2010, the incidence 
of all types of TB in South Africa was 981 per 100 000, whilst TB prevalence for the same 
period was 795 per 100 000 (Day, et al., 2011). Tuberculosis case notification rates have 
risen sharply, with an increase in the number of TB cases from 148 164 in 2004 to 401 048 in 
2010 (SANAC, 2011: p24). People living with HIV and infected with TB are 21 to 34 times 
more likely to develop TB disease compared to people with TB infection who are not HIV-
infected (Aurum Institute for Health Research, 2013). 
 
In communities where HIV prevalence exceeds 30% in pregnant women, annual tuberculosis 
notification rates as high as 1 468 per 100 000 population were reported in 2004 and 
continued to increase thereafter (Abdool Karim, Churchyard, Abdool Karim, & Lawn, 2009). 
Many TB cases are associated with HIV and over 50% of new TB cases are in patients with 
HIV co-infection. Even in communities where HIV prevalence has reached a plateau, TB 
rates continue to rise because of increasing levels of immunodeficiency (Abdool Karim, et 
al., 2009). Before the emergence of the HIV epidemic, the Western Cape Province had the 
highest rates of tuberculosis (Abdool Karim, et al., 2009). Currently, the number of 
tuberculosis cases and notification rates are highest in KwaZulu-Natal province (1066 per 
100 000 population in 2006), reflecting a combination of the highest HIV prevalence (39.1% 
in pregnant women in 2006) and the worst tuberculosis programme performance indicators 
(National Department of Health, 2008).  Historically, TB notification rates increased with 
advancing age, with men having a higher TB burden than women. Today, TB rates peak in 
women in their twenties and men in their thirties, which reflect the age distribution of HIV 
infection (Abdool Karim, et al., 2009). In 2006, Gauteng Province ranked fourth in terms of 
the TB burden in South Africa (Department of Health, 2007). 
 
TB mortality is defined as “the estimated number of deaths due to TB in a given time period, 
and is expressed as deaths per 100 000 population per year. TB mortality is one of the direct 
indicators of the burden of the disease as it indicates the number of people dying each year. 
Furthermore, mortality responds rapidly to improvements in control, as timely and effective 
treatment reduces the likelihood of dying from the disease (thus reducing disease-specific 
mortality)” (WHO, 2011: p94).  In 2007, the estimated TB mortality rate in South Africa was 
230 per 100 000 (WHO, 2011).  TB is a leading killer of people living with HIV (WHO, 
2013). Moreover, it has also shown to increase the risk of HIV progression and death, 
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particularly if HIV is untreated (McGaw, Lall, Meyer, & Eloff, 2008).  TB deaths continue to 
occur despite the availability of effective antimicrobial agents. Multi-drug resistance, HIV 
infection, and delayed therapy contribute to TB mortality (Sacks & Pendle, 2009). 
 
Although there is extensive information available on TB indicators, both globally and in 
South Africa, little is known about the profile of deaths at individual hospital level. Hence the 
focus of this study was on the profile of deaths at the Charles Hurwitz Hospital.  
 
1.1.1 Profile of Johannesburg Metropolitan District  
 
The boundaries of the Johannesburg Metropolitan health district (hereafter referred to as 
Johannesburg Metro) are co-terminous with those of the greater Johannesburg Metropolitan 
Municipality. Johannesburg Metro is one of five health districts
1
 within the Gauteng 
Province. The district has a population of 3.2 million and a population growth rate of 6.7%. 
The majority (83%) of the population are uninsured and are therefore dependent on the public 
health sector (Statistics South Africa, 2011).  
 
Johannesburg Metro is made up of seven health regions (A to G). There are 113 clinics, nine 
Community Health Centres, eight public hospitals, 20 private hospitals, numerous non-
governmental organisations and one MDR-TB unit.  Charles Hurwitz TB Hospital is located 
within the Johannesburg Metro (see Figure 1).  
  
                                                 
1
 At the time of the study, there were six health districts 
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Figure 1: Map of Gauteng with approximate location of Charles Hurwitz Hospital 
Source: www.google.co.za 
Note: Red star shows approximate hospital location 
As is the case in the rest of the country, the district has to implement the national 
Tuberculosis Control Programme (TBCP). The purpose of the TBCP programme is to 
improve case detection, case holding and treatment outcomes while prioritising infection 
control and TB/ HIV collaboration activities (Department of Health, 2007).  
 
In 2011, the incidence rate in the Johannesburg Metro district for all TB cases was 571 per 
100 000 population and 452 per 100 000 population for Pulmonary TB (PTB) cases. 
However, even within the district there are wide variations in incidence rates across the 
health regions.  For the period from April 2011 to March 2012, a total of 20 682 TB cases 
were registered on the electronic TB register within the JHB Metro (COJ, 2012).  
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1.1.2 Profile of Charles Hurwitz Hospital 
 
Charles Hurwitz TB Hospital was born out of the amalgamation of three TB centres. It is a 
specialised hospital rendering TB and other communicable disease treatment services to the 
community of Johannesburg. Charles Hurwitz TB Hospital is situated within the 
Johannesburg Metro in Region F. In April 2006, the management of the hospital was taken 
over by the Gauteng Department of Health from a non-government organisation (NGO) as 
part of the provincialisation project mandated by the National Health Act No 61 of 2003. The 
hospital is situated in the southern part of the City of Johannesburg on the outer boundaries of 
Soweto. It is 1.5m away from Chris Hani Baragwanath Hospital, one of the central, university 
teaching hospitals in Gauteng Province.   
 
Charles Hurwitz TB Hospital is used as a referral institution for the primary health care 
(PHC) clinics and other hospitals in the Johannesburg Metro district for: acutely ill patients 
already diagnosed with TB; complicated TB patients; and those with drug resistant TB, while 
awaiting the result of culture specimen to confirm the drug resistance.  
 
Charles Hurwitz is a 350-bed hospital with 12 adult wards and one children’s ward. The 
hospital is providing free services to all patients. Based on the hospital statistics, the racial 
profile of patients admitted to the hospital in 2007 was 72.8% black Africans; 20% coloureds 
and 7.2% Asians. (Charles Hurwitz Statistics, 2007).  
 
The hospital was providing anti-retroviral (ARV) treatment to patients with a CD count of 
350 and above and treatment initiation was only when the patient was out of the critical 
period. Patients were admitted for more than three months in the hospital and only discharged 
when they had converted to smear negative.  
 
At the time of the study in 2007, the researcher was the chief executive officer of the hospital. 
An analysis of routine information (monthly statistics and reports) suggested that the 
mortality figures were increasing in Charles Hurwitz TB Hospital.  
 
Locally, context specific information is important for the individual hospital manager to 
enable programme planning and possible interventions to prevent or reduce hospital deaths. 
In light of the importance of local, context specific information, this study was conducted 
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from January-December 2007 at the Charles Hurwitz Hospital in order to determine the 
profile of TB deaths.   
 
The remainder of this chapter sets the scene for the study that was conducted by outlining the 
problem statement, and presenting a brief review of existing literature on the profile of TB 
deaths. The chapter concludes with the rationale for the study.  
 
1.2 Problem Statement 
 
The prevention of TB mortality is a global priority (WHO, 2009), and is one of the key 
priorities in the strategic plan of the Department of Health in South Africa (Department of 
Health, 2007). Although extensive information is available on TB indicators (incidence, 
prevalence and mortality) at national and provincial levels, the profile of death at Charles 
Hurwitz was unknown. It was important from a management perspective to analyse the 
profile of deaths at the hospital, specifically: demographic profile of individuals who died, 
socio-economic information and information about treatment and care. Such information is 
important for programme planning, to improve quality of care, and to determine strategies for 
prevention or reduction of deaths. 
 
1.3 Literature review 
 
1.3.1 Definition of terms 
 
A new patient is defined as a patient who has never had treatment for TB or who has taken 
anti-tuberculosis drugs for less than four weeks (Department of Health, 2009: p28). 
 
A retreatment is defined as a patient who has taken TB treatment for four weeks or more in 
the past and either relapsed, defaulted or had treatment failure (Department of Health, 2009: 
p28).  
 
Treatment after relapse is defined as a sputum smear or culture-positive pulmonary TB client 
who received treatment and was declared cured or treatment completed at the end of the 
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treatment period and has now developed sputum smear or culture positive pulmonary TB 
again within two years (Department of Health, 2009: p28). 
 
Treatment after failure is defined as pulmonary TB client who is still sputum smear or culture 
positive at the end of the treatment period (Department of Health, 2009: p28).   
 
Treatment after default is defined as a patient who completed at least one month of treatment 
and returns after having interrupted treatment for two months or more, and is still smear or 
culture positive or has signs of active TB on clinical and radiological assessment (Department 
of Health, 2009: p28). 
 
Transfer in is defined as the client already registered for treatment in one district that has 
been transferred to another district to continue treatment is recorded as a “transfer in” at the 
receiving facility (Department of Health, 2009: p28). 
 
Moved in is defined as the client registered for treatment in one facility and moved to another 
facility within the same district (Department of Health, 2009: p28). 
 
TB mortality is defined as “the estimated number of deaths due to TB in a given time period, 
and is expressed as deaths per 100 000 population per year” (WHO, 2011: p94).  
 
1.3.2 Overview of initiatives to combat TB  
 
There have been a number of international, regional and national directives aimed at reducing 
the burden of TB. In 1993, WHO declared TB as a ‘global public health emergency’ (WHO, 
2009). The decade between 1995 and 2005, saw the directly observed treatment, short course 
[DOTS] strategy, which included DOTS supporters.  Goal 6 of the Millennium Development 
Goals (MDGs) focuses on combatting HIV/AIDS, malaria and other diseases (United 
Nations, 2011). The Stop TB Strategy succeeded the DOTS strategy, and is summarised in 
the table below (WHO, 2013). 
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Table 1: Overview of ‘The Stop TB Strategy’ 
 
Vision  Goal Objectives Components 
A TB-free 
world 
 
Reduce the global 
burden of TB by 2015 
in line with  
MDGs and the Stop TB 
Partnership targets 
 Achieve universal access to 
high-quality care for all 
people with TB 
 Reduce the human 
suffering and socio-
economic burden of TB 
 Protect vulnerable 
populations from TB, 
TB/HIV and drug-resistant 
TB 
 Support development of 
new tools and enable their 
timely and effective use 
 Protect and promote human 
rights in TB prevention, 
care and control 
 Pursue high-quality 
DOTS expansion and 
enhancement 
 Address TB/HIV, MDR-
TB, and the needs of poor 
and vulnerable 
populations Contribute to 
health system 
strengthening based on 
primary health care 
 Engage all care providers 
 Empower people with TB, 
and communities through 
partnership 
 Enable and promote 
research 
Source: WHO, 2013: page 2 
 
Forty six Ministers of Health unanimously declared TB an emergency in Africa. A resolution 
was taken to ensure urgent extraordinary action in preventing the scourge of TB that ravages 
the continent (Department of Health, 2007: p6). 
 
In South Africa, tuberculosis has been a priority for the new democratic government since 
1994. Following the WHO-AFRO Regional Committee meeting in 2005, the Minister of 
Health declared TB to be a national crisis and a TB crisis management plan was developed 
with the aim of intensifying the efforts to improve the TBCP (Department of Health, 2007). 
However, between 1996 and 2005, both the cure rates and successful treatment completion 
rates declined to 50% and 60% respectively, below the target set by WHO (Department of 
Health, 2009). The number of new tuberculosis cases doubled during the period from 2001 to 
2006, fuelled largely by the rampant HIV epidemic (Chopra et al., 2009). Gauteng Province 
was the province with the fourth largest TB caseload of 46 093 at the time (Department of 
Health, 2009). In 2010, the Minister of Health included TB prevention, management and 
control as one of the key priorities in the Negotiated Service Delivery Agreement signed with 
the President of South Africa (Department of Health, 2010).  
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South Africa’s national strategic plan on HIV, STIs and TB for the period 2012 until 2016 
contains the following sub-objectives:  “Ensure everyone in South Africa tests voluntarily for 
HIV and is screened for TB annually, and subsequently enrols in relevant wellness and 
treatment, care and support programmes” and “Prevent new TB infection and disease through 
IPT, infection control, early identification and treatment of TB and an improved TB cure 
rate” (SANAC, 2011: p39). 
 
1.3.3 Overview of TB mortality 
 
In 2012, there were an estimated 8.6 million new cases of TB and 1.3 million deaths, with 
320 000 of these deaths among HIV-positive people (WHO, 2013). In the same year, 
approximately one quarter of the world’s TB cases occurred in the Africa region, which also 
had the highest rates of deaths relative to population (WHO, 2013: p6). TB remains a disease 
that preys upon social disadvantage (Gandhi et al., 2006). 
 
The overwhelming majority of TB deaths take place in low- and middle-income countries 
(WHO, 2013). High mortality rates among TB patients, particularly early in treatment, have 
been reported in numerous settings (Harries, Hargreaves, Gausi, Kwanjana, & Salaniponi, 
2001). High mortality rates have been associated, with diagnostic delays, which occur most 
frequently in the case of smear-negative pulmonary TB and extra-pulmonary TB (EPTB) 
(Storla, Yimer, & Gunnar, 2008; Whitehorn, Ayles, & Godfrey-Faussett, 2010). Other risk 
factors for TB deaths include co-morbidities, HIV infection and multi-drug-resistant TB.  The 
figure below shows the estimated TB mortality rates globally (WHO, 2013). 
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Figure 2: Estimated TB mortality rates among HIV-negative people, 2012 
Source: WHO, 2013: page 20 
 
Figure 2 illustrates the burden of TB deaths in sub-Saharan Africa. Although the graph 
excludes TB deaths among HIV positive individuals, TB remains a leading cause of death 
among HIV-positive individuals (WHO, 2013). Hence, the risk factors or predictors for TB 
deaths are different in settings with low HIV prevalence. In Taiwan, for example, with a low 
HIV prevalence, a study conducted in a university hospital found that malignancy, liver 
cirrhosis, renal failure, and miliary and pneumonic radiographic patterns were the main 
predictors of  TB deaths (Lin et al., 2014). A study done at a hospital in Iran, found that  
anaemia, positive sputum smear,  smoking,  drug hepatitis,  drug use, and  history of previous 
TB were major risk factors for death among TB patients (Alavi-Naini, Moghtaderi, Metanat, 
Mohammadi, & Zabetian, 2013). In Brazil, a 2008 study found that TB was the leading cause 
of AIDS-related deaths despite free access to anti-retroviral treatment (Saraceni et al., 2008). 
 
In sub-Saharan Africa, the higher mortality in patients with smear negative pulmonary TB 
and extra-pulmonary tuberculosis (EPTB) has been attributed to misdiagnosis of HIV-related 
diseases (Cain, Thanomsak, Channawong, & et al, 2009). The Democratic Republic of Congo 
(DRC) is a high TB burden country, with an incidence rate of 372 per 100 000 population. A 
study found higher mortality rates among HIV-positive patients. The study also found 
increased risk of death among patients with smear-negative PTB and EPTB in the first 
11 
 
months of treatment for HIV-negative patients, and lower risk of death among EPTB cases 
who survived the first two months of treatment (Henegar, Behets, Van den, Driessche, & et 
al, 2012). 
 
A study that examined the predictors of mortality among TB-HIV co-infected patients treated 
for tuberculosis in Northwest Ethiopia found that mortality was high and strongly associated 
with the absence of ART during TB treatment. In addition cotrimoxazole prophylaxis  was an  
important factor in the reduction of mortality during TB treatment (Sileshi, Deyessa, Girma, 
Melese, & Suarez, 2013).  
 
1.3.4 TB death profile in South Africa 
 
In South Africa the proportion of extra-pulmonary TB deaths has risen from 5.2% to 7.4% of 
all TB deaths for the years 2001 to 2002. This could be partially due to HIV-related TB 
deaths (Nicolls, King, D., Bala, & del Rio, 2005). A report from Stats SA, South Africa’s 
official statistics agency, has recorded that the number of deaths between 1997 and 2002 in 
the age groups of 20 to 45 more than doubled, from over 100 000 to more than 200 000 
(Statistics South Africa, 2006).  Most of the deaths were likely to be linked to AIDS, but 
misclassified as deaths due to diseases such as TB and pneumonia. The age and disease 
pattern provided a strong evidence of the growing impact of AIDS. Two aspects of the report 
were particularly noteworthy, the death-certificate figures of sexually active women was 
rising significantly compared to male death certificate figures-which is a ratio that indicates 
the country’s AIDS-related mortality rate (Statistics South Africa, 2006).  
 
Figure 2 shows trends in TB death rates for new smear positive pulmonary TB cases for 
South Africa from 1994 until 2005 (Department of Health, 2007). As can be seen, the peak 
was reached in 1999, but TB death rates have remained unacceptable high as the national 
target for mortality rate is less than 2% (Department of Health, 2007). 
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Figure 3: Trends in TB death rates for new smear positive PTB cases, 1996-2005 
Source: Department of Health, 2007: page 12 
 
1.3.5 TB death profile in the Johannesburg Metro 
 
TB continues to be a persistent problem in the Johannesburg Metro and is associated with 
high mortality rates, especially among HIV infected people. In 2006, the Johannesburg Metro 
was one of the worst performing districts in the country (Department of Health, 2007). In the 
first quarter of 2006, the cure rate was 73.7%, the default rate was 7.8% and the death rate 
was 6.9% (Department of Health, 2007: p19). 
 
The District Health Barometer, an authoritative publication of the South African Health 
Systems Trust,  analysed the district’s 2009 burden of disease (BoD) profile (Massyn et al., 
2013). The authors noted that “Johannesburg’s 2009 quality of death certification was poor, 
with 38.3% of the certificates submitted not being useful for public health analysis. This is 
well above the South African mean of 30.2% and a long way from the internationally 
recognisable standard of 10%” (Massyn, et al., 2013), page 270.  Figure 3 below shows the 
years of life lost (YLL) for the Johannesburg Metro. As can be seen from the figure, the 
highest proportion of YLLs was due to TB (13.3%), with non-communicable diseases making 
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up a total of 37.4%. HIV and TB together accounted for 23.7% of YLL (Massyn, et al., 
2013).  
 
 
 
Figure 4: Leading causes of Years of Life Lost (YLLs): Johannesburg Metro District  
Source: Massyn, Day, Barron, Haynes, English, & Padarath, 2013:  page 270 
 
1.3.6 TB Profile in Charles Hurwitz TB Hospital  
 
In 2007, a management scan of the hospital records showed a high proportion of deaths when 
viewed against admissions (Table 2). There were no admissions during June 2008 because of 
the health worker strike in the province. 
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Table 2: Overview of key TB indicators at Charles Hurwitz Hospital, 2007 
 
Month Indicators 
 Admissions Discharges Deaths Deaths as percentage 
of admissions 
January 109 88 25 22.9% 
February 159 63 29 18.2% 
March 165 66 33 20% 
April 129 83 26 20.1% 
May 139 88 32 23% 
June 0 81 26 No admissions 
July 165 60 18 10.9% 
August 167 61 26 15.5% 
September 165 73 30 18.1% 
October 208 117 39 18.75% 
November 202 144 38 18.8% 
December 98 98 28 28.57% 
 
As can be seen from Table 2, deaths as a proportion of monthly admissions were very high. 
In January, the proportion of death was 22.9%.  July 2007 is the only month where the 
proportion of death was the lowest (10.9%). The proportion of death was at the highest in 
December 2007 with 28.6%. Hence it was a critical management imperative to understand 
the profile of deaths at Charles Hurwitz Hospital.  
 
1.4 Study Justification and Motivation 
 
During the study period, TB was managed as a disease on its own, and hospital treatment 
protocols did not necessarily take into cognisance co-infections with HIV or other diseases. 
Of particular concern was the increase in admissions and high mortality figures. There were 
several reasons for undertaking a study on the profile of deaths at Charles Hurwitz Hospital. 
Firstly, information on the profile of TB deaths could assist hospital management in 
developing appropriate strategies to prevent or reduce TB mortality. 
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Secondly, Gauteng Province as a whole was not performing well with a death rate of 9.6% 
(McGaw, et al., 2008). Importantly, the 2007 country report on progress with the MDGs 
listed the Johannesburg Metropolitan district as one of the fourth worst performing districts in 
the country (Republic of South Africa, 2007). 
 
It was envisaged that defining the profile of TB deaths would assist with valuable information 
to assess past outcomes of service delivery based on the TBCP guidelines and the norms and 
standards set by the Department of Health. Information gathered could also assist the 
referring facilities to be proactive and treat and refer appropriately in order to prevent 
unnecessary complications.   
 
It was also envisaged that the study would assist policy makers with locally context 
information to inform policies that could contribute towards the achievement of the MDGs.  
 
The next chapter describes the study methodology. 
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CHAPTER 2: METHODOLOGY
 
 
This chapter describes the study aim and objectives, as well as the methodology to answer the 
questions posed in this research. 
 
2.1 Aim of the Study  
 
The aim of the study was to describe the profile of TB deaths in Charles Hurwitz TB Hospital 
for the period January to December 2007.  
 
2.2 Objectives 
The specific objectives of the study were to:  
a. Describe the demographics of patients who died while admitted in Charles Hurwitz 
hospital 
b. Describe the socio-economic status of the patients who died 
c. Describe clinical profile and or risk factors of these patients 
d. Determine the TB disease classification using ICD 10 codes 
e. Assess whether the patient was co-infected with HIV when admitted 
f. Assess the treatment regimen that the patient was on  
g. Identify whether the patient was on ART or cotrimoxazole treatment while on TB 
treatment  
h. Describe the condition of the patient when admitted to hospital (e.g. level of 
consciousness or the critical state). 
2.3 Study setting 
The study setting was the Charles Hurwitz TB Hospital, the characteristics of which are 
described in Chapter 1. 
 
2.4 Ethical Issues 
Ethical clearance for the study was obtained from University of the Witwatersrand’s Human 
Research Ethics Committee (Medical) with reference number M091160 (Appendix 1). The 
Gauteng Department of Health and Social Development, through the Provincial Research 
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Committee, also gave approval for the study. Standard ethical procedures were adhered to for 
the review of patient records, and confidentiality was maintained of all information collected. 
 
2.5  Study Population  
 
The study population was all patients who died at the Charles Hurwitz hospital. 
 
2.6 Study period  
 
The study period was from 1 January until 31 December 2007. 
 
2.7 Study sample 
 
All hospital records of patients that died at Charles Hurwitz during the study period (January- 
December 2007) were used for the study.  This means that all records of patients who were 
admitted before the study period (January-December 2007) and who died within the study 
period and those admitted during the study period and died within the period of January-
December 2007 were included in the study.  
 
2.8 Study Design 
 
This was a descriptive study based on a retrospective record review of patients who died 
between January-December 2007 at Charles Hurwitz TB Hospital.    
 
2.9 Framework of analysis 
 
The framework of analysis of the study was the national strategic plan (Department of 
Health, 2007). Selected key targets contained in the plan and applicable to hospitals are 
contained in the table below. 
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Table 3: Targets used to frame data collection in the study 
 
Indicator Target 
Bacteriological coverage  100% 
Proportion of TB patients offered counselling and tested for 
HIV 
100% 
Proportion of HIV positive TB patients started on 
cotrimoxazole  
100% 
Proportion of HIV positive TB patients qualifying for ART 
and started on ART 
100% 
Source: Department of Health, 2007: page 20 
 
2.10 Data collection 
 
The study was conducted during 2009. All records of patients admitted in the hospital and 
who died during the study period January-December 2007 were reviewed. The first step 
consisted of sorting the records according to the patient category: new patient, re-treatment 
after failure, relapse after cure, re-treatment after default or all other re-treatment cases not 
included in the above mentioned categories.  Colour codes were used to distinguish among 
the records of the deceased: purple was used for new admissions, grey for re-treatment and 
black for HIV/AIDS infection.  
 
A summary of the information extracted from each patient’s record is shown in the table 
below and the standard data collection sheet is attached as Appendix 2. 
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Table 4:  Information collected from each patient record 
 
 Demographic information e.g. age and sex 
 Employment status, including work in the mining industry 
 Family history e.g. family member diagnosed with TB 
 History of smoking or alcohol consumption 
 Condition of the patient on admission (e.g. malnutrition, mental state or level of consciousness). 
 First episode of disease or re-treatment   
 Presence of other diseases e.g. diabetes, hypertension and epilepsy.   
 HIV Counselling, testing and treatment 
 
2.11 Data processing and analysis  
 
All data was kept in a safe storage area.  The information collected was captured into an 
Excel spreadsheet, and analysed using Microsoft Excel. Findings are presented through 
descriptive statistics using proportions, averages, percentages, tables, graphs and a narrative 
description.  
 
2.12 Study Limitations   
 
The study was limited to a review of the records of patients that died during January-
December 2007 while admitted in Charles Hurwitz TB Hospital. Information collected was 
only from what has been recorded in the records; there was no possibility of interviews or 
questionnaires to gather more information or to get clarity. Some history collected on 
admission by the hospital staff was sometimes from the sick patient without a next-of-kin to 
verify the information.  Hence, the limitations are those of record reviews, namely incomplete 
records, missing information and an inability to get clarity or additional information. The 
results of the study are discussed in the next chapter.  
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CHAPTER 3- RESULTS 
 
3.1 Introduction 
 
A total of 291 records of deceased TB patients were sampled at Charles Hurwitz TB 
Hospital for the study period from 1 January 2007 until 31 December 2007. 
 
3.2 Demographic and social profile of deceased TB patients 
 
The majority 97.9% (n=285) of deceased patients were black Africans, 1.7% (n=5) were 
coloured and 0.3% (n=1) was white. Just over one third 34.8% (n=101) of all the deceased 
patients was in the age group of 35-44 years and only 2.8% (n=8) were aged 65 years and 
above at the time of death (range from 8 years to 80 years) (see Figure 5). The mean age at 
death was 41 years (standard deviation = 10.9 years) and the median age was 39.5 years  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Age distribution of deceased TB patients, 2007 
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The majority of the patients 56.4% (n=163) were males and the remaining 43.6% (n=127) 
were females. Table 5 shows the age and sex distribution of the deceased TB patients at 
Charles Hurwitz Hospital for the study period. 
 
Table 5: Age and sex distribution of deceased TB patients, 2007 
 
Age (years) Females Males 
≤ 24 8 (88.9%) 1 (11.1%) 
25 - 34 44 (56.4%) 34 (43.6%) 
35 - 44 41 (40.6%) 60 (59.4%) 
45 - 54 25 (35.7%) 45 (64.3%) 
55 - 64 7 (29.2%) 17 (70.8%) 
≥ 65 2 (25.0%) 6 (75.0%) 
Total 127 (43.8%) 163 (56.2%) 
 
 
Table 6: Socio-demographic information on deceased TB patients, 2007 
 
Variable Yes  No  Missing 
information 
Employment (%) 109 (43.4%) 142 (56.6%) n=40 
(13.7%) Female-29 (26.6%) 
Male-80 (73.4%) 
Female-82 (56.3%) 
Male-60 (43.7%) 
Family TB contact (%) 28 (13.0%) 
 
187 (86.9%) n=76 
(26.1%) 
History of smoking 108 (42.0%) 
 
149 (58.0%) 
 
n=34 
(11.7%) 
 Female-34 (31.5%) 
Males-74 (68.5%) 
Female-97 (65.1%) 
Male-52 (34.9% 
Alcohol intake 152 (60.8%)  98 (39.2%) n=41 
(14.1%) Females-60 (34.5%) 
Males-92 (60.5%) 
Females-52(53.1%) 
Males-46 (46.9%) 
 
 
 
Table 6 indicates that only 28 or 13% of the deceased had a family history of TB contact. 
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The record review found that 108 of the study sample (42%) had a history of smoking, and 
the majority of these were males 74 (68.5%). The review also found that the majority of 
patients 152 (60.8%) reported alcohol consumption, with the majority being males 92 
(60.5%). Fewer than half 109 (43.4%) were employed, and the majority of these 80 
(73.4%) were males. The review found that 65/80 employed men (81.3%) had a history of 
being employed in the mining industry-61(93.8%) of the 65 males confirmed to have 
worked in the mines for more than five years. 
 
3.3 Clinical profile of deceased TB patients 
 
The record review found that eleven (3.8%) patients were admitted in a critical condition, 
they were diagnosed with advanced retroviral disease, presenting with confusion and 
disorientation. One patient was diagnosed with gross malnutrition and with a history of 
gastroenteritis.  
 
The majority of the patients (75.3%) were being treated for the first time. Table 7 shows the 
categories of deceased patients.  
 
Table 7:  Category of deceased TB patients 
 
Patient category No of patients % 
New patients 216 75.3 
Relapsed after cure  22 7.7 
Retreated after treatment completion (no 
cure)  
15 5.2 
Treatment interrupted 15 5.2 
Retreatment failure  7 2.4 
All other retreatment cases 6 2.1 
Retreated after default 6 2.1 
Total 287 100.0 
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3.3.1 Information on notification of TB 
 
The information on the TB notification for seven patients was missing. For those with 
complete information (n=284), the majority of TB cases (99.6%) were notified and in only 
one instance was the disease not notified.  
 
3.3.2 Classification of disease using ICD10 code 
 
The majority of the patients (66.6%) had a disease classification ICD10 code of A15/A16.2 
or positive for TB acid fast bacilli (Table 8).  
 
Table 8: Deceased TB patients according to ICD 10 codes 
 
ICD 10 Code Organ Affected No of patients % 
A15/A16.2 All AFB positive 193 66.6 
A15.2  All PTB 2 0.7 
A16.3 TB of the lymph nodes 3 1 
A16.5/A16.8 TB Pleura and other 
respiratory organs 
15 
5.2 
A16.7 Primary TB 1 0.3 
A17 TB meningitis 25 8.6 
A18.6/A18.8 TB other organs 19 6.6 
A19/A19.9 TB Miliary 32 11 
TOTAL  290 100 
 
3.3.3 Other medical conditions or treatment 
The review found that 54/291 (18.6%) suffered from co-morbidities. Two thirds 36/54 
(66.7%) of these patients with co-morbidities were on chronic medication for those 
conditions: eight (22%) were treated for hypertension; four (11%) were treated for 
hypotension; six (16.6%) were treated for diabetes; five (13.8%) were treated for epilepsy; 
four (11%) treated for anaemia; four (11%) were treated with chemotherapy, four (11%) were 
treated for mental health conditions. One female patient was pregnant at the time of death.  
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3.3.4 Sputum results 
 
The sputum results for 36 patients (12.4%) were not available. In those cases where the 
information was available, the majority of the deceased patients (62%) had a positive sputum 
result and the remaining (38%) had a negative sputum result.   
 
3.3.5 Diagnoses other than smear microscopy 
 
The use of other diagnostic tests other than smear microscopy is shown in the table below. 
 
Table 9: Use of other diagnostic tests 
 
Diagnosis No of patients % 
X-ray 124/291 42.6 
Cerebro-spinal fluid  23/291 7.9 
Biopsy 8/291 2.7 
 
3.3.6 Referred patients 
 
Information on referral was missing for eight patients. For those where information was 
available, almost half of the patients (127/283, 44.8%) were referred from other hospitals and 
clinics, while the remaining (156/283, 55.2%) were direct admissions to Charles Hurwitz TB 
Hospital.  
 
3.3.7 Type of Regimen and dosages 
 
Regimen 1 is administered for new cases and consists of Rifampicin, Isoniazid, Pyrazinamide 
and Ethambutol (RHZE). Regimen 1 is administered for any new patient for a continuous 
period of six months.  Regiment 2 is administered for re-treatment cases. It consists of 
Regimen 1 drugs plus a daily streptomycin injection. The period of treatment is for eight 
months depending on the smear conversion rate. Daily streptomycin injection is given for a 
period of two months. The majority of the deceased TB patients (68.7%) were administered 
regimen 1 (for new cases) and the remaining (31.3%) were administered regimen 2  
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Table 10:  Number of RHZE dosages (in months) 
 
RHZE Dosages (months)* No of patients % 
0 3 1.0 
2 20 7.0 
3 223 76.6 
4 45 15.4 
Total 291 100 
 
3.3.9 Patients on cotrimoxazole  
 
The majority of the patients (94.8%) were on cotrimoxazole prophylaxis treatment.  
 
3.4 TB-HIV co-infection  
 
3.4.1 HIV counselling  
The record review found that 202/291 (69.4%) of deceased individuals received HIV 
counselling. The remaining 89 patients (30.6%) either did not receive HIV counselling or it 
was not indicated in the patient record.   
 
3.4.2 HIV testing and treatment 
Although the records showed that only 69.4% of patients received HIV counselling, the 
majority 281 (96.6%) were tested for HIV. Of these, 239 (85.1%) were HIV positive, 3.9% 
negative, and 11% were awaiting HIV test results. The majority (95%) with HIV positive 
results were referred for anti-retroviral treatment (ART), but only 23.3% were actually on 
ART. This is graphically illustrated in the figure below. 
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Figure 6: HIV testing and treatment–deceased TB patients  
  
Deceased TB patients 
(n=291) 
Tested for HIV 
n=281 
(96.6%)) 
Not Tested for HIV 
n=10 
(3.4%) 
Awaiting Results 
n=31 
(11.0%) 
HIV positive 
n=239 
(85.1%) 
HIV negative 
n=11 
(3.9%) 
Referred for ART 
n=227 
95% 
Not Referred for ART 
n=12 
5 % 
On ART 
n=53  
(23.3%) 
Not on ART 
n=174 
(76.7%) 
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3.4.3 CD 4 counts of patients 
 
The CD4 count was only available for 138 out of 239 HIV positive patients (57.7%) and 
missing for the remainder of patients (42.3%). The mean CD4 count for the 138 patients was 
82.5 (SD=89.1), and the CD4 counts ranged from a low of 2 to a high of 441. The median 
CD4 count for the 138 patients was 45.9.   
 
Table 11 shows the distribution of the CD4 count for the deceased patients where information 
was available. As can be seen from the table, the majority of the patients (75/138, 54.3%) had 
a very low CD4 count of ≤ 50 CD4 cells/ µL, (48/138, 34.8%) had a low CD4 count of 51 – 
200,  (13/138, 9.4%) had a moderate CD4 count of 201 – 350,  and only (2/138, 1.4%) had a 
CD4 count higher than 350.   
 
Table 11:  Distribution of CD4 count  
 
CD4 cells/ µL No of patients % 
0 - 50 75 54.3 
51 - 200 48 34.8 
201 - 350 13 9.4 
> 350 2 1.4 
Total 138* 100 
*CD4 counts for 101 patients were missing 
 
3.5 Conclusion 
 
The mean age at death of all patients was 41 years and a median age of 39.5 years. Less than 
half of deceased individuals were employed (43.4%), more than one third had a history of 
smoking (42%) and the majority had a history of alcohol consumption (60.5%).  
 
The record review found that 11 patients (3.7%) were admitted in a critical condition. Almost 
three quarters of the patients (75.3%) were being treated for the first time. Almost one fifth of 
patients (18.6%) suffered from co-morbidities, the majority of whom were on chronic disease 
medication.   
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The review found that the majority of the patients (94.8%) were on cotrimoxazole 
prophylaxis treatment. Although the records showed that only 69.4% of patients received 
HIV counselling, the majority (96.6%) were tested for HIV. A staggering 85.1% of patients 
had HIV-TB co-infection. The majority (95%) of patients with HIV positive results were 
referred for anti-retroviral treatment (ART), but only 23.3% were actually on ART. A large 
number of records had missing information on CD4 tests, but in those cases where 
information on the CD4 count was available, the vast majority of patients had a very low 
CD4 count, with only two patients exceeding the threshold of 350 for treatment at the time of 
the study.  
 
The next two chapters will discuss the study findings in light of the existing literature, 
explore the implications of the findings, make recommendations and highlight issues 
requiring further investigation. 
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CHAPTER 4- DISCUSSION 
 
4.1 Introduction 
In this chapter, the findings of the study are discussed in relation to the study objectives and 
in light of the available literature. The chapter will also discuss the “missed opportunities”, 
defined as a failure to implement the key elements of the TBCP (specifically TB management 
and care interventions) to prevent potential TB deaths at the hospital.  
 
4.2 Socio-demographic information 
 
This was one of the first studies that examined the profile of deaths at the Charles Hurwitz 
TB hospital. The study found that the majority of TB patients at Charles Hurwitz Hospital 
died in the prime of their lives, with a mean age at death of 41 years and a median age of 39.5 
years. It confirms existing evidence that TB primarily affects adults in the economically 
active section of the population (WHO, 2013: p1). The findings contrast with a similar 
hospital-based study done in Taiwan where the mean age at death was 74 years (Lin, et al., 
2014). However, as indicated earlier, Taiwan is a low HIV prevalence setting, hence the 
much higher mean age at death.  
 
This study found that there were more male (56.4%), compared to female (43.6%) deaths at 
the Charles Hurwitz hospital, again confirming global evidence that TB is more common 
among men than women (WHO, 2013: p1). However, the findings in this Charles Hurwitz 
hospital study contrast evidence from the WHO Africa region which shows that more deaths 
occur among women than men in this region, compared to other WHO regions (WHO, 2013: 
p12). The study findings also contract with those of Stats SA, which showed a higher 
proportion of female deaths compared to male deaths for the period 1997 to 2002 (Statistics 
South Africa, 2006). This is because of the epidemiology of the HIV epidemic in this region, 
where women bear the brunt of the HIV epidemic in sub-Saharan Africa (Joint United 
Nations AIDS Programme & World Health Organization, 2009).  
 
The study found that the majority of the deceased were unemployed (56.6%), thus supporting 
the general finding that TB is a disease that affects poor people disproportionally (Coovadia, 
Jewkes, Barron, Sanders, & McIntyre, 2009; Gandhi, et al., 2006).  
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Almost one in two of deceased patients (42%) had a history of smoking, and the majority of 
these were males (68.5%). Similarly, almost two-thirds of patients (60.8%) reported alcohol 
consumption. A study done at a hospital in Iran also found that smoking and drug use, 
amongst others, were major risk factors for death among TB patients (Alavi-Naini, et al., 
2013). Both smoking and alcohol consumption are significant risk factors for TB infection, 
and their prevention are a major public health strategic priority (SANAC, 2011; WHO, 2013).  
 
This study conducted in 2007 in Charles Hurwitz hospital found that 81.3% (65/80) of the 
employed men had a history of employment in the mining industry,  61/65 (93.8%)  males 
confirmed working  in the mines for more than five years  (first paragraph  p22).  
 
The study found that 81.3% of the employed men had a history of employment in the mining 
industry in excess of five years. This is not surprising as analysts have pointed to the 
epidemic burden of mining-related occupational diseases, including TB (Murray, Davies, & 
Rees, 2011; Ndlovu, te Water Naude, & Murray, 2013).  
 
4.3 Clinical profile of deceased TB patients 
 
Although 75.3% of deceased patients were new TB patients who were being treated for the 
first time, 24.7% of TB patients were because of different forms of relapse or retreatment 
(Table 7). This finding illustrates the challenge (or failure) of the health system to manage TB 
patients according to the existing standards specified in the national TBCP (Department of 
Health, 2007).  
 
Notwithstanding the missing records of seven patients, the study found that all but one patient 
were notified; hence it appears that there is relatively good compliance with the disease 
notification system. 
 
Although the majority of the patients (66.6%) in this study at Charles Hurwitz had a disease 
classification ICD10 code of A15/A16.2 or positive for TB acid fast bacilli (Table 8), there 
was almost one third of extra-pulmonary TB cases.  This figure is much higher than the 
average of 15% of extra-pulmonary TB cases for South Africa as a whole (Department of 
Health, 2007: p10). Other studies have found that extra-pulmonary TB, often made worse by 
diagnostic delays, contribute to high mortality rates (Storla, et al., 2008; Whitehorn, et al., 
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2010). A DRC study also found increased risk of death among patients with smear-negative 
PTB and EPTB in the first months of treatment for HIV-negative patients (Henegar, et al., 
2012). 
 
In this study at Charles Hurwitz, almost one in five deceased patients (18.6%) suffered from 
co-morbidities. It is not clear from the records whether all of these individuals were in need 
of chronic disease medication. Nonetheless, only 66.7% of patients with co-morbidities were 
on chronic medication, indicating a missed treatment opportunity. These co-morbidities are 
known risk factors that increase the risk of progressing from latent infection to active TB 
disease (WHO, 2013: p93).  The Iran hospital study also found that drug hepatitis and 
diabetes mellitus were independent predictors of death among TB patients (Alavi-Naini, et 
al., 2013). 
 
The sputum results for one in eight patients (12.4%) were not available. More than one third 
(38%) had a negative sputum result in those cases where the information was available.  As is 
the case with extra-pulmonary TB, studies have found that smear-negative cases of TB are 
also associated with higher mortality (Henegar, et al., 2012; Storla, et al., 2008; Whitehorn, et 
al., 2010). 
 
The study found that although three-quarters of patients (75.3%) were classified as new 
patients, 68.7% were administered regimen 1 (for new cases). It is unclear why there is this 
discrepancy in treatment, but it may indicate non-compliance with the TBCP.   
 
Cotrimoxazole preventive therapy given in conjunction with TB treatment has also been 
shown to reduce overall mortality during treatment for HIV-positive patients (WHO, 2013). 
South Africa’s national HIV and AIDS policy guidelines recommend daily cotrimoxazole 
prophylaxis for all HIV positive adults, regardless of the existence of TB (SANAC, 2011) 
Encouragingly, the study found that 94.8% of patients were on cotrimoxazole prophylaxis 
treatment. However, as cotrimoxazole is known to reduce TB mortality (Sileshi, et al., 2013; 
WHO, 2013), the expected figure of patients on cotrimoxazole prophylaxis is 100%. 
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4.4 TB-HIV co-infection 
 
The study found that a staggering 85.1% of deceased patients suffered from TB-HIV co-
infection. The lethal combination of TB-HIV co-infection, and the consequences for 
morbidity and mortality have been well described (Abdool Karim, et al., 2009; Chopra, et al., 
2009; Coovadia, et al., 2009; Department of Health, 2007; Henegar, et al., 2012; Saraceni, et 
al., 2008; Sileshi, et al., 2013; WHO, 2011, 2013).  In 2012, worldwide there were 13 TB 
deaths per 100 000 population, but this figure increased to 17.6 when TB deaths among HIV-
positive people were included (WHO, 2013: p19).  
 
Although the record review showed that the majority of deceased patients (96.6%) were 
tested for HIV, only 23.3% of HIV positive individuals referred for treatment (or 22% of 
those who tested positive) were actually on ART. WHO has indicated that “ART is a critical 
intervention for reducing the risk of TB morbidity and mortality among HIV positive 
individuals living with HIV, as treatment reduces the individual risk of TB disease by 65%, 
irrespective of CD4 cell count” (WHO, 2013: p71).  A study in Ethiopia also found that 
mortality was high among TB-HIV co-infected patients, and strongly associated with the 
absence of ART during TB treatment (Sileshi, et al., 2013). A study in Zimbabwe has also 
demonstrated the positive impact of ART on the survival of TB-HIV co-infected patients 
(MacPherson et al., 2011). 
 
The study found that the mean CD4 count for those 138 patients where information was 
available was 82.5 (SD=89.1), the median CD4 count was 45.9, and the CD4 counts ranged 
from a low of 2 to a high of 441. The Ethiopia study found that low CD4 counts of less than 
75 cells/μl had an increased risk of mortality during TB treatment (Sileshi, et al., 2013). 
Hence, all of these TB-HIV patients at Charles Hurwitz should have been on ART in light of 
their very low CD4 counts, and as recommended by the WHO.  
 
4.5 Missed opportunities in the TB treatment and care continuum 
 
The study found that there were several missed opportunities in the TB treatment and care 
continuum, as has been found in another study that focused on prevention of mother-to-child 
HIV transmission (Rispel, Peltzer, Phaswana-Mafuya, Metcalf, & Treger, 2009). In this study 
at Charles Hurwitz Hospital, the missed opportunities started at the admission of the patient 
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with the failure to obtain socio-demographic information and the failure to provide HIV 
counselling to all the patients. There were also several missed opportunities related to TB 
treatment, the management of co-morbidities and the management of TB-HIV co-infection.   
These missed opportunities are highlighted in the diagram below.  
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Figure 7: Missed opportunities in the management and care of deceased TB patients 
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35 
 
Overall the many missed opportunities indicate sub-optimal compliance with the TBCP at the 
hospital, both at the clinical and management levels. Further research is needed to determine 
whether these missed opportunities occurred, or whether it was simply a case of missing 
information.  
 
4.5 Study strengths and limitations  
 
This was a retrospective record review carried out in at a government TB hospital in Gauteng 
province, and the findings cannot be generalised to all TB hospitals in South Africa. As with 
all record reviews, information was missing on a number of items under investigation. It is 
unclear, for example, whether all the missed opportunities highlighted in the previous 
sections were indeed the situation, or simply because of missing information. Nonetheless, 
the quality of recording in patient records is in itself of concern, as these are legal documents. 
The problem of useable information was also highlighted in the District Health Barometer, 
hence this is a general issue that needs to be addressed (Massyn, et al., 2013). Lastly, a 
limitation of the study is that it focused on deaths that occurred during 2007 at the hospital, 
and there may have been improvements in many of the indicators measured.  
 
There are strengths of this research study. This was one of the first studies to examine the 
profile of deaths at the Charles Hurwitz TB hospital. It describes the socio-economic profile, 
TB treatment indicators and management of TB-HIV co-infection, as well as the performance 
of the hospital against the TBCP. It was relatively cheap to execute as no field-work was 
needed. The study provides valuable information for clinical management at the hospital, for 
programme or service planning, which is important in light of the global burden of TB, with 
the global number of people dying of TB in 2012 at around 1·3 million  (WHO, 2013). 
 
4.6 Conclusion 
 
The study found that there were many missed opportunities in TB management and care at 
the Charles Hurwitz Hospital. The final chapter focuses on the recommendations, based on 
the findings of the study. 
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CHAPTER 5- RECOMMENDATIONS 
 
5.1 Introduction 
 
TB is a complex disease that targets people with compromised immune systems e.g. those 
who are HIV infected.  In spite of new modalities for diagnosis and treatment for TB, people 
are still suffering and TB is still the top infectious disease killer, second only to HIV (WHO, 
2013). Using a retrospective record review, this study sought to describe the profile of deaths 
at Charles Hurwitz TB Hospital.  The study generated locally, context specific information on 
the: demographic profile of deceased patients; the clinical profile of these deceased patients; 
and the management and care of TB-HIV infection, as it is one of the main predictors of 
mortality. The key results of the study were presented and discussed in the previous chapters. 
The study findings underscore the need for better compliance with the national TBCP.  
 
South Africa has well formulated and broadly accepted strategic plans for HIV, STIs and TB, 
sufficient political will and adequate capacity to deliver on many of the urgently needed 
health-care interventions that can contribute to the country’s response to the twin epidemics 
of TB and HIV (SANAC, 2011). The recently established Office of Health Standards 
Compliance provides an opportunity to ensure greater compliance to existing norms and 
standards.  Hence, the recommendations in Chapter 5 derive from the study findings and the 
existing TB policies, guidelines and strategies in South Africa.  
 
5.2 Recommendations 
The main recommendations are summarised in the table below. 
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Table 12: Summary of recommendations 
 
Hospital level 
 
 All admission clerks should receive training on the importance of obtaining and completing 
the prescribed social and demographic information from patients 
 All health professionals (doctors, nurses, etc.)  should receive ongoing training on the national 
TBCP, especially the importance of  combatting TB and preventing deaths, as well as global 
initiatives (such as the Stop TB campaign) 
 A hospital quality assurance programme should be established to ensure compliance with 
guidelines and standards contained in the TBCP & the NSP on HIV, STIs &TB-the monthly 
morbidity and mortality meetings should be enforced 
 Strengthen linkages with district and community-based services  
 
Policy level 
 
 There should be annual performance monitoring to ensure that all facilities report on 
compliance with existing TB guidelines and plans 
 
5.2.1 Hospital level recommendations 
 
The study found that the quality of record keeping was sub-optimal, with missing information 
from a large number of records. All admission clerks at the hospital should receive training 
on the importance of obtaining and completing the prescribed social and demographic 
information from patients upon admission. If patients are too ill, an attempt should be made 
to obtain the information from the next-of-kin. The hospital management team should 
monitor compliance with the information contained in patient records, and that it is in 
accordance with the National Health Act (Republic of South Africa, 2005). 
 
All health professionals (doctors and nurses, and other categories) should receive training on 
the latest guidelines on the management of TB, and TB-HIV co-infection. They should be 
sensitised on the importance of combatting TB and preventing deaths, and be oriented to the 
main national and global initiatives. Journal clubs and in-service training sessions should be 
organised. All health professionals should have access to appropriate guidelines and protocols 
that enable them to meet the required needs of all TB, as well as HIV positive patients. 
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The health professionals should be oriented to the notion of missed opportunities in 
management and care of patients, and they should develop joint solutions on avoiding missed 
opportunities. 
 
The hospital CEO should establish a hospital quality assurance programme, if this is not 
already the case, to ensure compliance with guidelines and standards contained in the TBCP 
& the NSP on HIV, STIs &TB. A quality champion should be appointed. The clinical 
manager at the hospital should provide oversight of the quality assurance programme, which 
will also reduce or eliminate missed opportunities. Hospital specific level targets should be 
developed in line with national guidelines, and these should be monitored at a regular level. 
The monthly morbidity and mortality meetings should be enforced, as potentially avoidable 
deaths can be discussed and remedial steps taken at an early level. 
 
The hospital should also strengthen linkages with district and community-based services, 
particularly campaigns that encourage community members to attend health facilities and to 
seek care for a persistent or chronic cough. All TB patients must be screened for HIV, and 
HIV counselling must be compulsory for all patients. Health promotion at both individual and 
different levels of the health system must be encouraged.  
 
The World Health Organization’s Stop TB campaign reaffirms recommendations for 
supervised treatment, as well as the use of fixed-dose combinations of anti-TB drugs and 
patient kits as further measures for preventing the acquisition of drug resistance (WHO, 
2013). Closer liaison with district services will allow the hospital to influence the training or 
orientation of community health care workers. The key focus must be on the prevention, early 
treatment and ensuring the survival of TB patients, and achieving a death rate of less than 2% 
(SANAC, 2011).  
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5.2.1 Policy recommendations 
 
There should be annual performance monitoring to ensure that all facilities report on 
compliance with existing TB guidelines and plans. Feedback is critical, as well as the 
development of strategies to ensure that remedial action is taken early. 
 
The policy framework is in place to ensure the prevention of TB deaths. The implementation 
requires strong leadership, political will, social mobilisation, adequate human and financial 
resources, and sustainable development of health services. (SANAC, 2011). Management of 
TB must be monitored and it must be a team’s effort to ensure that the MDG 2015 and the 
NDP goals are achieved.  
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